hotspot -WSS

hotspot

author：entertainment 2025-09-04 14:14:52 Page View：86599

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tennessee woman gets emergency hysterectomy after doctors deny early abortion care
Next article： Guidelines to prevent youth baseball injuries need more muscle

leisure time

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

With fresh data, a dynamic duo powers Eli Lilly to new heights

EliLillyCEODavidRicks(left)andChiefScientificOfficerDanielS.SkovronskyMollyFergusonforSTATThepartner

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

What the cancer research community can learn from the Covid response

TinaReed,PaulKluetz,JohnOyler,andSolangePetersspeakattheMilkenInstituteFutureofHealthSummit.Screenca

hotspot

explore

leisure time

What the cancer research community can learn from the Covid response